Efficacy and mechanism of Shugan Jieyu combined with sertraline in alcohol-dependent patients with depression: A randomized clinical study

舍曲林 医学 内科学 萧条(经济学) 抗抑郁药 哈姆德 不利影响 随机对照试验 汉密尔顿抑郁量表 心情 评定量表 重性抑郁障碍 临床试验 临床研究 联合疗法 治疗组和对照组 治疗效果 临床疗效 抑郁症状 安慰剂 入射(几何) 药物治疗 显著性差异
作者
Yan Zhang,Hao-Yu-xing,Juan Yan
出处
期刊:World journal of psychiatry [Baishideng Publishing Group Co (World Journal of Psychiatry)]
卷期号:15 (12)
标识
DOI:10.5498/wjp.v15.i12.111801
摘要

BACKGROUND Proper antidepressant use can improve mood and reduce desire to drink alcohol in alcohol-induced-affective-disorder patients. Shugan Jieyu capsules (SJC) have various impacts on the central nervous system, producing antidepressant effects. Traditional Chinese medicine (including Shugan Jieyu) is highly therapeutic in treating alcohol dependence, with few side-effects. However, research on its combination with Western antidepressants (e.g., sertraline) to improve patients’ depression is insufficient. AIM To evaluate the clinical efficacy and safety of SJC combined with sertraline vs sertraline monotherapy in alcohol-dependent patients with comorbid depression. METHODS We conducted a randomized, double-blind, placebo-controlled trial. Sixty patients (aged 18-65 years) were randomly assigned to two groups (n = 30 per group). Primary outcome: Hamilton Depression Rating Scale (HAMD)-17 changes over 6 weeks. Benzodiazepines were permitted for severe insomnia. RESULTS The HAMD-17 score of the study (vs control) group was lower at treatment weeks 2, 4, and 6 (P < 0.05). Regarding intra-group comparisons, the study group’s HAMD score was significantly lower than that before treatment from week 2 (P < 0.05), while that of the control group was significantly lower than that before treatment from week 4 (P < 0.05). The study and control groups’ total efficacy rates were 90% and 73.3%, respectively, showing a significant difference in efficacy (χ² = 4.812, P = 0.028). No significant difference was observed in adverse reactions’ incidence between the groups at treatment weeks 2, 4, and 6 (P > 0.05). CONCLUSION SJC-sertraline combination therapy accelerates depressive symptom relief (by 2 weeks) and improves response rates (+16.7%) in alcohol-dependent patients, without increasing adverse events. Clinical outcomes suggest potential synergistic mechanisms, though no biomarker analyses were performed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
舒心的语儿完成签到,获得积分20
刚刚
刚刚
蔡媛发布了新的文献求助10
刚刚
刚刚
上彐下火发布了新的文献求助10
刚刚
Lucas应助纪你巴采纳,获得10
1秒前
大模型应助WWwww采纳,获得10
1秒前
王同学发布了新的文献求助30
1秒前
2秒前
3秒前
3秒前
drclin完成签到,获得积分20
4秒前
4秒前
瓶子君152完成签到,获得积分10
4秒前
山奈完成签到,获得积分20
5秒前
孙久惠jiuh完成签到,获得积分10
5秒前
科研通AI6应助ng9jR2采纳,获得10
5秒前
十一完成签到,获得积分10
5秒前
6秒前
姜歪歪完成签到 ,获得积分10
7秒前
7秒前
量子星尘发布了新的文献求助10
7秒前
双椒兔丁发布了新的文献求助10
7秒前
logy发布了新的文献求助10
7秒前
8秒前
8秒前
阿冰发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
10秒前
10秒前
kxdr完成签到,获得积分10
11秒前
12秒前
核桃发布了新的文献求助10
12秒前
山奈发布了新的文献求助10
12秒前
内向夜山应助1101592875采纳,获得10
13秒前
Owen应助NEKO采纳,获得10
13秒前
liushikai发布了新的文献求助10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Iron toxicity and hematopoietic cell transplantation: do we understand why iron affects transplant outcome? 2000
List of 1,091 Public Pension Profiles by Region 1021
Teacher Wellbeing: Noticing, Nurturing, Sustaining, and Flourishing in Schools 1000
A Technologist’s Guide to Performing Sleep Studies 500
EEG in Childhood Epilepsy: Initial Presentation & Long-Term Follow-Up 500
Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5480809
求助须知:如何正确求助?哪些是违规求助? 4581983
关于积分的说明 14382905
捐赠科研通 4510577
什么是DOI,文献DOI怎么找? 2471918
邀请新用户注册赠送积分活动 1458281
关于科研通互助平台的介绍 1431940